No Data
Lyra Health Advances Health Equity With Proactive Social Care Solution
Lyra Therapeutics Granted U.S. Patent #12036337 For "IMPLANTABLE SCAFFOLDS FOR TREATMENT OF SINUSITIS".
Express News | Cantor Fitzgerald Reiterates Overweight on Lyra Therapeutics
Lyra Therapeutics Analyst Ratings
Express News | Lyra Therapeutics Estimates That It Will Incur Charges Of About $3.9M-$4.1M In Connection With The Workforce Reduction; Expects That The Majority Of Charges Related To Workforce Reduction Will Be Incurred In Q2 Of 2024
Express News | Lyra Therapeutics: Expects That the Majority of Charges Related to Workforce Reduction Will Be Incurred in the Second Quarter of 2024
TrytosaveabitOP : Wish this news woulda come on a day when the NASDAQ isn’t down 500pts! Hehehe